As National Epilepsy Awareness Month begins on Saturday, new survey findings from SK Life Science, Inc., a global leader in ...

Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapies for disorders of the nervous system, today announced that its lead product candidate, NRTX-1001, ...

Please provide your email address to receive an email when new articles are posted on . ORLANDO — Although effective treatments have been established for those with epilepsy, there is a need for more ...

For the millions of people worldwide living with severe forms of epilepsy, some do not respond to medication and it can be ...

Axsome obtains exclusive global rights to AZD7325, a novel oral selective GABAA α2,3 receptor positive allosteric modulator ...

Medication has long been the cornerstone of treatment for people with epilepsy, but it doesn't stop seizures for everyone and ...

Rice University bioengineers have demonstrated a nonsurgical way to quiet a seizure-relevant brain circuit in an animal model ...

TOLEDO, Ohio (WTVG) - Dravet Syndrome is a rare and severe form of epilepsy. Treatment options are limited and a local family is working to help change that. The family is hosting an event later this ...

Scientists from Laval University and the University of Texas Southwestern Medical Center have joined forces to understand ...

Biopharmaceutical researchers are working to create a future where patients get the right medicines the first time. According to the Epilepsy Foundation, one-third of people with epilepsy live with ...

In today’s Health Headlines, can treatment-resistant epilepsy improve over time? Are melatonin supplements bad for your heart ...

Veterans who develop epilepsy following a traumatic brain injury (TBI) face a higher risk of death than veterans with ...